Innovation in microsampling for therapeutic drug monitoring of gentamicin in neonates: a proof-of-concept study

Int J Antimicrob Agents. 2022 Feb;59(2):106513. doi: 10.1016/j.ijantimicag.2021.106513. Epub 2022 Jan 6.

¹ UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia. Electronic address: suzanne.parker@uq.edu.au.
² UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia; Infection Management and Prevention Service, Children's Health Queensland Hospital and Health Service, Brisbane, Australia.
³ Grantley Stable Neonatal Unit, Royal Brisbane and Women's Hospital, Brisbane, Australia.
⁴ Grantley Stable Neonatal Unit, Royal Brisbane and Women's Hospital, Brisbane, Australia; School of Nursing and Midwifery, Griffith University, Brisbane, Australia.
⁵ UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia.
⁶ UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia; Department of Intensive Care Medicine, Royal Brisbane & Women's Hospital, Brisbane, Australia; Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France.
⁷ UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia; Department of Intensive Care Medicine, Royal Brisbane & Women's Hospital, Brisbane, Australia; Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France; Department of Pharmacy, Royal Brisbane & Women's Hospital, Brisbane, Australia.

No abstract available

Publication types